[go: up one dir, main page]

ECSP045200A - Acidos 3-(imidazolil)-2-alcoxipropanoicos - Google Patents

Acidos 3-(imidazolil)-2-alcoxipropanoicos

Info

Publication number
ECSP045200A
ECSP045200A EC2004005200A ECSP045200A ECSP045200A EC SP045200 A ECSP045200 A EC SP045200A EC 2004005200 A EC2004005200 A EC 2004005200A EC SP045200 A ECSP045200 A EC SP045200A EC SP045200 A ECSP045200 A EC SP045200A
Authority
EC
Ecuador
Prior art keywords
alcoxipropanoicos
imidazolil
acids
alkyl
hydrogen
Prior art date
Application number
EC2004005200A
Other languages
English (en)
Spanish (es)
Inventor
Charlotte Moira Norfor Allerton
David John Bull
Mark Edward Bunnage
Robert John Maguire
John Steele
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0201389A external-priority patent/GB0201389D0/en
Priority claimed from GB0202027A external-priority patent/GB0202027D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of ECSP045200A publication Critical patent/ECSP045200A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EC2004005200A 2002-01-22 2004-07-22 Acidos 3-(imidazolil)-2-alcoxipropanoicos ECSP045200A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0201389A GB0201389D0 (en) 2002-01-22 2002-01-22 3-(imidazolyl)-2-alkoxypropanoic acids
GB0202027A GB0202027D0 (en) 2002-01-29 2002-01-29 3-(imidazolyl)-2-alkoxypropanoic acids

Publications (1)

Publication Number Publication Date
ECSP045200A true ECSP045200A (es) 2004-08-27

Family

ID=27614792

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005200A ECSP045200A (es) 2002-01-22 2004-07-22 Acidos 3-(imidazolil)-2-alcoxipropanoicos

Country Status (24)

Country Link
EP (1) EP1467731A1 (fr)
JP (1) JP2005520811A (fr)
KR (1) KR20040077775A (fr)
CN (1) CN1620291A (fr)
AP (1) AP2004003084A0 (fr)
AR (1) AR038197A1 (fr)
BR (1) BR0307016A (fr)
CA (1) CA2472238A1 (fr)
EA (1) EA200400716A1 (fr)
EC (1) ECSP045200A (fr)
HR (1) HRP20040659A2 (fr)
IL (1) IL162677A0 (fr)
IS (1) IS7310A (fr)
MA (1) MA27167A1 (fr)
MX (1) MXPA04006573A (fr)
NO (1) NO20043457L (fr)
OA (1) OA12756A (fr)
PA (1) PA8563501A1 (fr)
PE (1) PE20030929A1 (fr)
PL (1) PL371487A1 (fr)
TN (1) TNSN04121A1 (fr)
TW (1) TW200302094A (fr)
UY (1) UY27615A1 (fr)
WO (1) WO2003061652A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005051384A1 (fr) * 2003-11-25 2005-06-09 Pfizer Limited Compositions pharmaceutiques stabilisees
EP1874322A1 (fr) * 2005-04-18 2008-01-09 Bayer Schering Pharma Aktiengesellschaft Utilisation d'inhibiteurs de tafi pour ameliorer la reperfusion myocardique et faciliter la pci
JPWO2010050525A1 (ja) 2008-10-29 2012-03-29 大正製薬株式会社 TAFIa阻害活性を有する化合物
US8987242B2 (en) 2008-12-05 2015-03-24 Merck Sharp & Dohme Corp. Morpholinone compounds as factor IXA inhibitors
US8642582B2 (en) 2008-12-05 2014-02-04 Merck Sharp & Dohme Corp. Morpholinone compounds as factor IXa inhibitors
CA2793523C (fr) 2010-03-18 2015-05-05 Daiichi Sankyo Company, Limited Derive d'acide cyclopropanecarboxylique
SG10201502026XA (en) * 2010-03-18 2015-05-28 Daiichi Sankyo Co Ltd Cycloalkyl-substituted imidazole derivative
CA2914533A1 (fr) 2013-06-10 2014-12-18 Sanofi Derives d'uree macrocycliques utiles en tant qu'inhibiteurs de tafia, leur preparation et leur utilisation en tant que produits pharmaceutiques
US20190117624A1 (en) 2016-03-29 2019-04-25 Daiichi Sankyo Company, Limited Therapeutic agent for inflammatory bowel diseases
WO2019054427A1 (fr) 2017-09-14 2019-03-21 第一三共株式会社 Composé à structure cyclique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901572D0 (sv) * 1999-05-03 1999-05-03 Astra Ab New compounds
CA2419633C (fr) * 2000-08-17 2011-05-10 Pfizer Inc. Imidazoles substitues utilises comme inhibiteurs tafia

Also Published As

Publication number Publication date
HRP20040659A2 (en) 2004-10-31
PA8563501A1 (es) 2004-08-31
JP2005520811A (ja) 2005-07-14
IL162677A0 (en) 2005-11-20
TW200302094A (en) 2003-08-01
PE20030929A1 (es) 2003-11-05
EP1467731A1 (fr) 2004-10-20
AR038197A1 (es) 2005-01-05
CA2472238A1 (fr) 2003-07-31
MXPA04006573A (es) 2004-10-04
CN1620291A (zh) 2005-05-25
OA12756A (en) 2006-07-03
MA27167A1 (fr) 2005-01-03
TNSN04121A1 (en) 2006-06-01
NO20043457L (no) 2004-08-19
KR20040077775A (ko) 2004-09-06
EA200400716A1 (ru) 2004-12-30
WO2003061652A1 (fr) 2003-07-31
BR0307016A (pt) 2004-11-03
AP2004003084A0 (en) 2004-09-30
IS7310A (is) 2004-06-14
WO2003061652A8 (fr) 2004-09-10
UY27615A1 (es) 2003-08-29
PL371487A1 (en) 2005-06-13

Similar Documents

Publication Publication Date Title
UY27522A1 (es) Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
NO20005237D0 (no) Heterocyklisk substituerte amider anvendt som calpain- inhibitorer
ES2184280T3 (es) Compuestos de indol como inhibidores de cox-2'.
NO20052469L (no) Inhibitorer av II-beta-hydroksysteroid-dehydrogenase type 1 og type 2.
PE20050999A1 (es) Cetoamidas novedosas con p4 ciclicos como inhibidores de ns3 serina proteasa del virus de hepatitis c
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
PE20060570A1 (es) Compuestos de quinazolina e isoquinolina piperidilo sustituidos como inhibidores de fosfodiesterasa pde-10
ATE404538T1 (de) Tetrahydropyranylcyclopentyltetrahydroisochino- linmodulatoren der chemokinrezeptoraktivität
PE20050226A1 (es) Productos aril-heteroaromaticos y composiciones que los contienen
CO6150147A2 (es) Derivados de 5,6-bisaril-2-piridin-carboxamida su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de urotensina ii
CO5580762A2 (es) Analogos de lipoxina a4
ECSP045200A (es) Acidos 3-(imidazolil)-2-alcoxipropanoicos
AR042362A1 (es) Derivados de 3h-quinazolin-4-ona, proceso de obtencion y composiciones farmaceuticas que los contienen
PE20040528A1 (es) Inhibidores de la peptido-deformilasa
MXPA04005940A (es) Acidos 3-(imidazolil)-2-aminopropanoicos.
PE20050120A1 (es) Camptotecinas con un anillo de lactona modificada
AR040140A1 (es) Derivados de esteres de camptotecina en la posicion 20
PE20030611A1 (es) Compuestos basicos lineales que tienen actividad antagonista de nk-2 y sus formulaciones
EA200701866A1 (ru) Стабилизирующая композиция для галогенидсодержащих полимеров
DE60124717D1 (de) Aryl-sulfonamide als serotonin-antagonisten für de behandlung von fettleibigkeit
AR053339A1 (es) Composiciones para el tratamiento del cabello y/o del cuero cabelludo
PE20060103A1 (es) Nuevas 5-acilindolinonas con contenido en cicloalquilo y su preparacion como medicamento
DOP2003000564A (es) Acidos 3-(imidazolil)-2-alcoxipropanoicos
BRPI0508471A (pt) hidróxi-6-fenilfenantridinas substituìdas por difluoroetóxi
PE20010165A1 (es) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinil-aminometilcromano como antagonistas de la sustancia p